<!DOCTYPE html>
<html lang="en">
    <head>
		<!-- Google tag (gtag.js) -->
		<script async src="https://www.googletagmanager.com/gtag/js?id=G-WC8DLV9RM8"></script>
		<script>
		window.dataLayer = window.dataLayer || [];
		function gtag(){dataLayer.push(arguments);}
		gtag('js', new Date());

		gtag('config', 'G-WC8DLV9RM8');
		</script>
		<!-- more standard info -->
		<title>Publications</title>
		<meta charset="utf-8" />
		<meta name="viewport" content="width=device-width, initial-scale=1, user-scalable=no" />
		<link rel="stylesheet" href="../assets/css/main.css" />
		<noscript><link rel="stylesheet" href="../assets/css/noscript.css" /></noscript>
	</head>
  <body class="is-preload">
    <!-- Navigation menu Start -->
		<header class="header" id="header">
			<nav class="nav container">
			  <div class="nav__menu" id="nav-menu">
				<ul class="nav__list">
				  <li class="nav__item">
					<a href="../index.html" class="nav__link">
						<i class="bi bi-arrow-up-right"></i>
						<span>Home</span>
					</a>
				  </li>
				  <li class="nav__item">
					<a href="publications.html" class="nav__link">
					  <i class="bi bi-arrow-up-right"></i>
					  <span>Publications</span>
					</a>
				  </li>
				  <li class="nav__item">
					<a href="talks.html" class="nav__link">
					  <i class="bi bi-arrow-up-right"></i>
					  <span>Talks</span>
					</a>
				  </li>
				  <li class="nav__item">
					<a href="network.html" class="nav__link">
					  <i class="bi bi-arrow-up-right"></i>
					  <span>International network</span>
					</a>
				  </li>
				  <!-- <li class="nav__item">
					<a href="team.html" class="nav__link">
					  <i class="bi bi-arrow-up-right"></i>
					  <span>Team</span>
					</a>
				  </li> -->
				  <li class="nav__item">
					<a href="biography.html" class="nav__link">
					  <i class="bi bi-arrow-up-right"></i>
					  <span>Biography</span>
					</a>
				  </li>
				</ul>
				<!-- Close End -->
				<!-- Social Start -->
				<div class="nav__social">
				  <a href="https://x.com/FuEdouard" target="_blank" class="nav__social-link">
					<i class="bi bi-instagram"><span class="icon brands style1 fa-x-twitter"></span></i>
				  </a>
				  <a href="https://www.linkedin.com/in/edouardfu/" target="_blank" class="nav__social-link">
					<i class="bi bi-github"><span class="icon brands style1 fa-linkedin-in"></span></i>
				  </a>
				  <a href="mailto: e.l.fu@lumc.nl" target="_blank" class="nav__social-link">
					<i class="bi bi-facebook"><span class="icon regular style1 fa-envelope"></span></i>
				  </a>
				</div>
				<!-- Sociel End -->
			  </div>
			  <!-- Toggle Start -->
			  <div class="nav__toggle" id="nav-toggle">
				<i class="bi bi-list"><span class="icon solid fa-bars"></span></i>
			  </div>
			  <!-- Toggle End -->
			</nav>
		  </header>
		  <!-- Navigation menu End -->

		<!-- Research highlights -->
		  <section class="wrapper style1 align-left" id="all-publications">
			<div class="inner material">

				<h2>Journal publications</h2>
				<div><b>Number of papers:</b> 74 <br>
                     <b>Number of first authorships:</b> 24<br>
                     <b>Number of last authorships:</b> 2 <br>
                     <b>Total number of citations:</b> 2224 <br>
                     <b>H-index:</b> 25 <br></div>
				<br>
				<p>For a summary of research highlights instead, see <a href="../index.html#publications">this overview</a> </p>

				<table>
					<thead>
						<tr>
							<th>Authors</th>
							<th>Title</th>
							<th>Journal</th>
							<th>Date</th>
							<th>PMID</th>
						</tr>
					</thead>
					<tbody>
						<tr><td>Mahalingasivam V, Faucon AL, Sjölander A, Bosi A, González-Ortiz A, Lando S, <b>Fu EL</b>, Nitsch D, Bruchfeld A, Evans M, Wing K, Mansfield KE, Tomlinson L, Carrero JJ</td><td>Kidney Function Decline After COVID-19 Infection.</td><td><i>JAMA Netw Open</i></td><td>2024</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/39724377" target="_blank">39724377</a></td></tr><tr><td>Tanaka S, Bosi A, <b>Fu EL</b>, Iseki K, Kitazono T, Hultgren R, Faucon AL, Carrero JJ</td><td>Kidney Function, Kidney Function Decline, and the Risk of Abdominal Aortic Aneurysm: The Stockholm CREAtinine Measurements (SCREAM) Project.</td><td><i>Eur J Vasc Endovasc Surg</i></td><td></td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/39706328" target="_blank">39706328</a></td></tr><tr><td>Ballew SH, Sang Y, Coresh J, <b>Fu EL</b>, Nitsch D, Carrero JJ, Grams ME</td><td>Incorporation of Cystatin C Testing in Clinical Practice: Real World Experience in Sweden.</td><td><i>Kidney Int Rep</i></td><td>2024</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/39698352" target="_blank">39698352</a></td></tr><tr><td>Loureiro Harrison L, <b>Fu EL</b>, Thomson PC, Traynor JP, Mark PB, Stoumpos S</td><td>Impact of arteriovenous fistula formation on trajectory of kidney function decline: a target trial emulation.</td><td><i>Clin Kidney J</i></td><td>2024</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/39687920" target="_blank">39687920</a></td></tr><tr><td>Heinen FJ, Peijster AJL, <b>Fu EL</b>, Kamp O, Chamuleau SAJ, Post MC, van der Stoel MD, Keyhan-Falsafi MA, van Nieuwkoop C, Klautz RJM, Tanis W, Cardiothoracic Surgery Registration Committee of the Netherlands Heart Registration</td><td>External validation of EuroSCORE I and II in patients with infective endocarditis: results from a nationwide prospective registry.</td><td><i>Eur J Cardiothorac Surg</i></td><td>2024</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/39579090" target="_blank">39579090</a></td></tr><tr><td>Lambourg EJ, <b>Fu EL</b>, McGurnaghan S, Conway BR, Dhaun N, Grant CH, Pearson ER, Mark PB, Petrie J, Colhoun H, Bell S, Scottish Diabetes Research Network Epidemiology Group</td><td>Stopping Versus Continuing Metformin in Patients With Advanced CKD: A Nationwide Scottish Target Trial Emulation Study.</td><td><i>Am J Kidney Dis</i></td><td></td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/39521399" target="_blank">39521399</a></td></tr><tr><td>Bosi A, Xu Y, Faucon AL, Huang T, Evans M, Shin JI, <b>Fu EL</b>, Carrero JJ</td><td>Hyperkalemia and maintenance of renin-angiotensin system inhibitor therapy after initiating SGLT-2 or DPP-4 inhibitors.</td><td><i>Nephrol Dial Transplant</i></td><td></td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/39384578" target="_blank">39384578</a></td></tr><tr><td>Mazhar F, Faucon AL, <b>Fu EL</b>, Szummer KE, Mathisen J, Gerward S, Reuter SB, Marx N, Mehran R, Carrero JJ</td><td>Systemic inflammation and health outcomes in patients receiving treatment for atherosclerotic cardiovascular disease.</td><td><i>Eur Heart J</i></td><td>2024</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/39211962" target="_blank">39211962</a></td></tr><tr><td>Zoccali C, Tripepi G, Stel V, <b>Fu EL</b>, Mallamaci F, Dekker F, Jager KJ</td><td>Decoy receptors as biomarkers for exploring aetiology and designing new therapies.</td><td><i>Clin Kidney J</i></td><td>2024</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/39184952" target="_blank">39184952</a></td></tr><tr><td>Huang T, Bosi A, Faucon AL, Grams ME, Sjölander A, <b>Fu EL</b>, Xu Y, Carrero JJ</td><td>GLP-1RA vs DPP-4i Use and Rates of Hyperkalemia and RAS Blockade Discontinuation in Type 2 Diabetes.</td><td><i>JAMA Intern Med</i></td><td>2024</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/39133509" target="_blank">39133509</a></td></tr><tr><td>Zoccali C, Tripepi G, Carioni P, <b>Fu EL</b>, Dekker F, Stel V, Jager KJ, Mallamaci F, Hymes JL, Maddux FW, Stuard S</td><td>Antihypertensive Drug Treatment and the Risk for Intrahemodialysis Hypotension.</td><td><i>Clin J Am Soc Nephrol</i></td><td>2024</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/39012707" target="_blank">39012707</a></td></tr><tr><td><b>Fu EL</b>, Wexler DJ, Cromer SJ, Bykov K, Paik JM, Patorno E</td><td>SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study.</td><td><i>BMJ</i></td><td>2024</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/38925801" target="_blank">38925801</a></td></tr><tr><td>Zoccali C, Tripepi G, Stel V, <b>Fu EL</b>, Mallamaci F, Dekker F, Jager KJ</td><td>Biomarkers in clinical epidemiology studies.</td><td><i>Clin Kidney J</i></td><td>2024</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/38915440" target="_blank">38915440</a></td></tr><tr><td>O'Hara DV, Janse RJ, <b>Fu EL</b>, Jardine MJ, Carrero JJ</td><td>Adherence and persistence to novel glucose-lowering medications in persons with type 2 diabetes mellitus undergoing routine care.</td><td><i>Diabetes Res Clin Pract</i></td><td>2024</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/38876274" target="_blank">38876274</a></td></tr><tr><td>Hall RK, Kazancıoğlu R, Thanachayanont T, Wong G, Sabanayagam D, Battistella M, Ahmed SB, Inker LA, Barreto EF, <b>Fu EL</b>, Clase CM, Carrero JJ</td><td>Drug stewardship in chronic kidney disease to achieve effective and safe medication use.</td><td><i>Nat Rev Nephrol</i></td><td>2024</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/38491222" target="_blank">38491222</a></td></tr><tr><td><b>Fu EL</b>, Carrero JJ, Sang Y, Evans M, Ishigami J, Inker LA, Grams ME, Levey AS, Coresh J, Ballew SH</td><td>Association of Low Glomerular Filtration Rate With Adverse Outcomes at Older Age in a Large Population With Routinely Measured Cystatin C.</td><td><i>Ann Intern Med</i></td><td>2024</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/38285982" target="_blank">38285982</a></td></tr><tr><td>Odler B, <b>Fu EL</b></td><td>eGFR slope as a primary endpoint for clinical trials of CKD progression: one size fits all?</td><td><i>Clin Kidney J</i></td><td>2024</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/38264677" target="_blank">38264677</a></td></tr><tr><td>Gonzalez-Ortiz A, Clase CM, Bosi A, <b>Fu EL</b>, Pérez-Guillé BE, Faucon AL, Evans M, Zoccali C, Carrero JJ</td><td>Evaluation of the introduction of novel potassium binders in routine care; the Stockholm CREAtinine measurements (SCREAM) project.</td><td><i>J Nephrol</i></td><td>2024</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/38236474" target="_blank">38236474</a></td></tr><tr><td><b>Fu EL</b>, Mastrorilli J, Bykov K, Wexler DJ, Cervone A, Lin KJ, Patorno E, Paik JM</td><td>A population-based cohort defined risk of hyperkalemia after initiating SGLT-2 inhibitors, GLP1 receptor agonists or DPP-4 inhibitors to patients with chronic kidney disease and type 2 diabetes.</td><td><i>Kidney Int</i></td><td>2024</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/38101515" target="_blank">38101515</a></td></tr><tr><td><b>Fu EL</b>, Levey AS, Inker LA, Carrero JJ</td><td>Authors' Reply: Integer Cystatin C Values: Impact on Discordance Group Assignment and Accuracy of GFR-Estimating Equations.</td><td><i>J Am Soc Nephrol</i></td><td>2023</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/37921833" target="_blank">37921833</a></td></tr><tr><td>Zoccali C, Mallamaci F, Tripepi G, <b>Fu EL</b>, Stel VS, Dekker FW, Jager KJ</td><td>The long-term benefits of early intensive therapy in chronic diseases-the legacy effect.</td><td><i>Clin Kidney J</i></td><td>2023</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/37915902" target="_blank">37915902</a></td></tr><tr><td><b>Fu EL</b>, Desai RJ, Paik JM, Kim DH, Zhang Y, Mastrorilli JM, Cervone A, Lin KJ</td><td>Comparative Safety and Effectiveness of Warfarin or Rivaroxaban Versus Apixaban in Patients With Advanced CKD and Atrial Fibrillation: Nationwide US Cohort Study.</td><td><i>Am J Kidney Dis</i></td><td>2024</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/37839687" target="_blank">37839687</a></td></tr><tr><td><b>Fu EL</b>, Levey AS, Coresh J, Grams ME, Faucon AL, Elinder CG, Dekker FW, Delanaye P, Inker LA, Carrero JJ</td><td>Accuracy of GFR estimating equations based on creatinine, cystatin C or both in routine care.</td><td><i>Nephrol Dial Transplant</i></td><td>2024</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/37813817" target="_blank">37813817</a></td></tr><tr><td>Writing Group for the CKD Prognosis Consortium, Grams ME, Coresh J, Matsushita K, Ballew SH, Sang Y, Surapaneni A, Alencar de Pinho N, Anderson A, Appel LJ, Ärnlöv J, Azizi F, Bansal N, Bell S, Bilo HJG, Brunskill NJ, Carrero JJ, Chadban S, Chalmers J, Chen J, Ciemins E, Cirillo M, Ebert N, Evans M, Ferreiro A, <b>Fu EL</b>, Fukagawa M, Green JA, Gutierrez OM, Herrington WG, Hwang SJ, Inker LA, Iseki K, Jafar T, Jassal SK, Jha V, Kadota A, Katz R, Köttgen A, Konta T, Kronenberg F, Lee BJ, Lees J, Levin A, Looker HC, Major R, Melzer Cohen C, Mieno M, Miyazaki M, Moranne O, Muraki I, Naimark D, Nitsch D, Oh W, Pena M, Purnell TS, Sabanayagam C, Satoh M, Sawhney S, Schaeffner E, Schöttker B, Shen JI, Shlipak MG, Sinha S, Stengel B, Sumida K, Tonelli M, Valdivielso JM, van Zuilen AD, Visseren FLJ, Wang AY, Wen CP, Wheeler DC, Yatsuya H, Yamagata K, Yang JW, Young A, Zhang H, Zhang L, Levey AS, Gansevoort RT</td><td>Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis.</td><td><i>JAMA</i></td><td>2023</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/37787795" target="_blank">37787795</a></td></tr><tr><td>Xu Y, Faucon AL, <b>Fu EL</b>, Carrero JJ</td><td>Routine care data and the benefits of GLP1 receptor agonists on slowing kidney function decline.</td><td><i>Kidney Int</i></td><td>2023</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/37599022" target="_blank">37599022</a></td></tr><tr><td>Bosi A, Clase CM, Ceriani L, Sjölander A, <b>Fu EL</b>, Runesson B, Chang Z, Landén M, Bellocco R, Elinder CG, Carrero JJ</td><td>Absolute and Relative Risks of Kidney Outcomes Associated With Lithium vs Valproate Use in Sweden.</td><td><i>JAMA Netw Open</i></td><td>2023</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/37418264" target="_blank">37418264</a></td></tr><tr><td>Chatur S, <b>Fu EL</b>, Vaduganathan M</td><td>Interpreting Nonrandomized Evidence for Clinical Decision Making in Cardio-Oncology.</td><td><i>JACC CardioOncol</i></td><td>2023</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/37397081" target="_blank">37397081</a></td></tr><tr><td>Carrero JJ, <b>Fu EL</b>, Sang Y, Ballew S, Evans M, Elinder CG, Barany P, Inker LA, Levey AS, Coresh J, Grams ME</td><td>Discordances Between Creatinine- and Cystatin C-Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical Practice.</td><td><i>Am J Kidney Dis</i></td><td>2023</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/37354936" target="_blank">37354936</a></td></tr><tr><td>Faucon AL, <b>Fu EL</b>, Stengel B, Mazhar F, Evans M, Carrero JJ</td><td>A nationwide cohort study comparing the effectiveness of diuretics and calcium channel blockers on top of renin-angiotensin system inhibitors on chronic kidney disease progression and mortality.</td><td><i>Kidney Int</i></td><td>2023</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/37330214" target="_blank">37330214</a></td></tr><tr><td><b>Fu EL</b>, Patorno E, Everett BM, Vaduganathan M, Solomon SD, Levin R, Schneeweiss S, Desai RJ</td><td>Sodium-glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort study.</td><td><i>Eur Heart J</i></td><td>2023</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/37259575" target="_blank">37259575</a></td></tr><tr><td>Xu Y, Dong S, <b>Fu EL</b>, Sjölander A, Grams ME, Selvin E, Carrero JJ</td><td>Long-term Visit-to-Visit Variability in Hemoglobin A(1c) and Kidney-Related Outcomes in Persons With Diabetes.</td><td><i>Am J Kidney Dis</i></td><td>2023</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/37182597" target="_blank">37182597</a></td></tr><tr><td><b>Fu EL</b></td><td>Target Trial Emulation to Improve Causal Inference from Observational Data: What, Why, and How?</td><td><i>J Am Soc Nephrol</i></td><td>2023</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/37131279" target="_blank">37131279</a></td></tr><tr><td><b>Fu EL</b>, Tomlinson LA, Carrero JJ</td><td>Renin-Angiotensin System Inhibition in Advanced CKD.</td><td><i>N Engl J Med</i></td><td>2023</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/37043662" target="_blank">37043662</a></td></tr><tr><td><b>Fu EL</b>, Levey AS, Coresh J, Elinder CG, Rotmans JI, Dekker FW, Paik JM, Barany P, Grams ME, Inker LA, Carrero JJ</td><td>Accuracy of GFR Estimating Equations in Patients with Discordances between Creatinine and Cystatin C-Based Estimations.</td><td><i>J Am Soc Nephrol</i></td><td>2023</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/36995139" target="_blank">36995139</a></td></tr><tr><td><b>Fu EL</b>, D'Andrea E, Wexler DJ, Patorno E, Paik JM</td><td>Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with CKD and Type 2 Diabetes: Population-Based US Cohort Study.</td><td><i>Clin J Am Soc Nephrol</i></td><td>2023</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/36827225" target="_blank">36827225</a></td></tr><tr><td><b>Fu EL</b>, Kutz A, Desai RJ</td><td>Finerenone in chronic kidney disease and type 2 diabetes: the known and the unknown.</td><td><i>Kidney Int</i></td><td>2023</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/36603981" target="_blank">36603981</a></td></tr><tr><td>Mazhar F, Sjölander A, <b>Fu EL</b>, Ärnlöv J, Levey AS, Coresh J, Carrero JJ</td><td>Estimating the prevalence of chronic kidney disease while accounting for nonrandom testing with inverse probability weighting.</td><td><i>Kidney Int</i></td><td>2023</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/36462535" target="_blank">36462535</a></td></tr><tr><td>Alkas J, Bosi A, Sjölander A, Barany P, Elinder CG, <b>Fu EL</b>, Carrero JJ</td><td>Novel glucose-lowering drugs and the risk of acute kidney injury in routine care; the Stockholm CREAtinine Measurements (SCREAM) project.</td><td><i>J Nephrol</i></td><td>2023</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/36459371" target="_blank">36459371</a></td></tr><tr><td>Xu H, Garcia-Ptacek S, Bruchfeld A, <b>Fu EL</b>, Shori TD, Lindholm B, Eriksdotter M, Carrero JJ</td><td>Association between cholinesterase inhibitors and kidney function decline in patients with Alzheimer's dementia.</td><td><i>Kidney Int</i></td><td>2023</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/36341731" target="_blank">36341731</a></td></tr><tr><td>Lyu B, Sang Y, Selvin E, Chang AR, Alexander GC, Cohen CM, Coresh J, Shalev V, Chodick G, Karasik A, Carrero JJ, <b>Fu EL</b>, Xu Y, Grams ME, Shin JI</td><td>Pharmacologic Treatment of Type 2 Diabetes in the U.S., Sweden, and Israel.</td><td><i>Diabetes Care</i></td><td>2022</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/36282149" target="_blank">36282149</a></td></tr><tr><td>Carrero JJ, <b>Fu EL</b>, Vestergaard SV, Jensen SK, Gasparini A, Mahalingasivam V, Bell S, Birn H, Heide-Jørgensen U, Clase CM, Cleary F, Coresh J, Dekker FW, Gansevoort RT, Hemmelgarn BR, Jager KJ, Jafar TH, Kovesdy CP, Sood MM, Stengel B, Christiansen CF, Iwagami M, Nitsch D</td><td>Defining measures of kidney function in observational studies using routine health care data: methodological and reporting considerations.</td><td><i>Kidney Int</i></td><td>2023</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/36280224" target="_blank">36280224</a></td></tr><tr><td>Trevisan M, Hjemdahl P, Clase CM, de Jong Y, Evans M, Bellocco R, <b>Fu EL</b>, Carrero JJ</td><td>Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants.</td><td><i>Am J Kidney Dis</i></td><td>2023</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/36208798" target="_blank">36208798</a></td></tr><tr><td>Bhatt AS, Vaduganathan M, Zhuo M, <b>Fu EL</b>, Solomon SD, Desai RJ</td><td>Risk of Acute Kidney Injury Among Older Adults With Heart Failure and With Reduced Ejection Fraction Treated With Angiotensin-Neprilysin Inhibitor vs Renin-Angiotensin System Inhibitor in Routine Clinical Care.</td><td><i>J Card Fail</i></td><td>2023</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/36191759" target="_blank">36191759</a></td></tr><tr><td>Swartling O, Yang Y, Clase CM, <b>Fu EL</b>, Hecking M, Hödlmoser S, Trolle-Lagerros Y, Evans M, Carrero JJ</td><td>Sex Differences in the Recognition, Monitoring, and Management of CKD in Health Care: An Observational Cohort Study.</td><td><i>J Am Soc Nephrol</i></td><td>2022</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/35906075" target="_blank">35906075</a></td></tr><tr><td>Janse RJ, <b>Fu EL</b>, Dahlström U, Benson L, Lindholm B, van Diepen M, Dekker FW, Lund LH, Carrero JJ, Savarese G</td><td>Use of guideline-recommended medical therapy in patients with heart failure and chronic kidney disease: from physician's prescriptions to patient's dispensations, medication adherence and persistence.</td><td><i>Eur J Heart Fail</i></td><td>2022</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/35851740" target="_blank">35851740</a></td></tr><tr><td><b>Fu EL</b>, Coresh J, Grams ME, Clase CM, Elinder CG, Paik J, Ramspek CL, Inker LA, Levey AS, Dekker FW, Carrero JJ</td><td>Removing race from the CKD-EPI equation and its impact on prognosis in a predominantly White European population.</td><td><i>Nephrol Dial Transplant</i></td><td>2023</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/35689668" target="_blank">35689668</a></td></tr><tr><td>Janse RJ, <b>Fu EL</b>, Clase CM, Tomlinson L, Lindholm B, van Diepen M, Dekker FW, Carrero JJ</td><td>Stopping versus continuing renin-angiotensin-system inhibitors after acute kidney injury and adverse clinical outcomes: an observational study from routine care data.</td><td><i>Clin Kidney J</i></td><td>2022</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/35664269" target="_blank">35664269</a></td></tr><tr><td>Ocak G, Khairoun M, Khairoun O, Bos WJW, <b>Fu EL</b>, Cramer MJ, Westerink J, Verhaar MC, Visseren FL, UCC-SMART study group</td><td>Chronic kidney disease and atrial fibrillation: A dangerous combination.</td><td><i>PLoS One</i></td><td>2022</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/35390012" target="_blank">35390012</a></td></tr><tr><td>Hödlmoser S, Carrero JJ, Kurnikowski A, <b>Fu EL</b>, Swartling O, Winkelmayer WC, Schernhammer ES, Hecking M</td><td>Kidney Function, Kidney Replacement Therapy, and Mortality in Men and Women.</td><td><i>Kidney Int Rep</i></td><td>2022</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/35257057" target="_blank">35257057</a></td></tr><tr><td><b>Fu EL</b>, Clase CM, Janse RJ, Lindholm B, Dekker FW, Jardine MJ, Carrero JJ</td><td>Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice.</td><td><i>Int J Cardiol</i></td><td>2022</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/35074492" target="_blank">35074492</a></td></tr><tr><td>Chesnaye NC, Stel VS, Tripepi G, Dekker FW, <b>Fu EL</b>, Zoccali C, Jager KJ</td><td>An introduction to inverse probability of treatment weighting in observational research.</td><td><i>Clin Kidney J</i></td><td>2022</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/35035932" target="_blank">35035932</a></td></tr><tr><td>Trevisan M, <b>Fu EL</b>, Carrero JJ</td><td>Reply to the letter regarding the article 'Stopping mineralocorticoid receptor antagonists after hyperkalaemia: trial emulation in data from routine care'.</td><td><i>Eur J Heart Fail</i></td><td>2022</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/34989103" target="_blank">34989103</a></td></tr><tr><td><b>Fu EL</b>, Evans M, Carrero JJ, Putter H, Clase CM, Caskey FJ, Szymczak M, Torino C, Chesnaye NC, Jager KJ, Wanner C, Dekker FW, van Diepen M</td><td>Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study.</td><td><i>BMJ</i></td><td>2021</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/34844936" target="_blank">34844936</a></td></tr><tr><td>Xu Y, <b>Fu EL</b>, Clase CM, Mazhar F, Jardine MJ, Carrero JJ</td><td>GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes.</td><td><i>Kidney Int</i></td><td>2022</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/34826514" target="_blank">34826514</a></td></tr><tr><td>Xu Y, <b>Fu EL</b>, Trevisan M, Jernberg T, Sjölander A, Clase CM, Carrero JJ</td><td>Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes.</td><td><i>Am Heart J</i></td><td>2022</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/34610282" target="_blank">34610282</a></td></tr><tr><td>Trevisan M, <b>Fu EL</b>, Xu Y, Jager K, Zoccali C, Dekker FW, Carrero JJ</td><td>Pharmacoepidemiology for nephrologists (part 1): concept, applications and considerations for study design.</td><td><i>Clin Kidney J</i></td><td>2021</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/34221367" target="_blank">34221367</a></td></tr><tr><td>Trevisan M, <b>Fu EL</b>, Xu Y, Savarese G, Dekker FW, Lund LH, Clase CM, Sjölander A, Carrero JJ</td><td>Stopping mineralocorticoid receptor antagonists after hyperkalaemia: trial emulation in data from routine care.</td><td><i>Eur J Heart Fail</i></td><td>2021</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/34196082" target="_blank">34196082</a></td></tr><tr><td><b>Fu EL</b>, van Diepen M, Xu Y, Trevisan M, Dekker FW, Zoccali C, Jager K, Carrero JJ</td><td>Pharmacoepidemiology for nephrologists (part 2): potential biases and how to overcome them.</td><td><i>Clin Kidney J</i></td><td>2021</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/33959262" target="_blank">33959262</a></td></tr><tr><td>Windahl K, EQUAL study investigators, Irving GF, Almquist T, Lidén MK, Stenvinkel P, Chesnaye NC, Drechsler C, Szymczak M, Krajewska M, <b>Fu EL</b>, Torino C, Porto G, Roderick P, Caskey FJ, Wanner C, Dekker FW, Jager KJ, Evans M</td><td>Patient-Reported Measures and Lifestyle Are Associated With Deterioration in Nutritional Status in CKD Stage 4-5: The EQUAL Cohort Study.</td><td><i>J Ren Nutr</i></td><td>2022</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/33931314" target="_blank">33931314</a></td></tr><tr><td>Zhang JLH, Appelman-Dijkstra NM, <b>Fu EL</b>, Rotmans JI, Schepers A</td><td>Practice variation in the treatment of patients with renal hyperparathyroidism: a survey-based study in the Netherlands.</td><td><i>BMC Nephrol</i></td><td>2021</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/33892650" target="_blank">33892650</a></td></tr><tr><td>Clase CM, <b>Fu EL</b>, Jardine M, Mann JFE, Carrero JJ</td><td>Cloth Masks May Prevent Transmission of COVID-19.</td><td><i>Ann Intern Med</i></td><td>2021</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/33872538" target="_blank">33872538</a></td></tr><tr><td>de Jong Y, <b>Fu EL</b>, van Diepen M, Trevisan M, Szummer K, Dekker FW, Carrero JJ, Ocak G</td><td>Validation of risk scores for ischaemic stroke in atrial fibrillation across the spectrum of kidney function.</td><td><i>Eur Heart J</i></td><td>2021</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/33769473" target="_blank">33769473</a></td></tr><tr><td><b>Fu EL</b>, Evans M, Clase CM, Tomlinson LA, van Diepen M, Dekker FW, Carrero JJ</td><td>Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study.</td><td><i>J Am Soc Nephrol</i></td><td>2021</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/33372009" target="_blank">33372009</a></td></tr><tr><td><b>Fu EL</b>, Clase CM, Evans M, Lindholm B, Rotmans JI, Dekker FW, van Diepen M, Carrero JJ</td><td>Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.</td><td><i>Am J Kidney Dis</i></td><td>2021</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/33246024" target="_blank">33246024</a></td></tr><tr><td><b>Fu EL</b>, van Diepen M</td><td>Comment on Kwon et al. The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease. Diabetes Care 2020;43:948-955.</td><td><i>Diabetes Care</i></td><td>2020</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/33082247" target="_blank">33082247</a></td></tr><tr><td><b>Fu EL</b>, Uijl A, Dekker FW, Lund LH, Savarese G, Carrero JJ</td><td>Association Between β-Blocker Use and Mortality/Morbidity in Patients With Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction and Advanced Chronic Kidney Disease.</td><td><i>Circ Heart Fail</i></td><td>2020</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/33070637" target="_blank">33070637</a></td></tr><tr><td>Clase CM, <b>Fu EL</b>, Ashur A, Beale RCL, Clase IA, Dolovich MB, Jardine MJ, Joseph M, Kansiime G, Mann JFE, Pecoits-Filho R, Winkelmayer WC, Carrero JJ</td><td>Forgotten Technology in the COVID-19 Pandemic: Filtration Properties of Cloth and Cloth Masks-A Narrative Review.</td><td><i>Mayo Clin Proc</i></td><td>2020</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/33012350" target="_blank">33012350</a></td></tr><tr><td><b>Fu EL</b>, Janse RJ, de Jong Y, van der Endt VHW, Milders J, van der Willik EM, de Rooij ENM, Dekkers OM, Rotmans JI, van Diepen M</td><td>Acute kidney injury and kidney replacement therapy in COVID-19: a systematic review and meta-analysis.</td><td><i>Clin Kidney J</i></td><td>2020</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/32897278" target="_blank">32897278</a></td></tr><tr><td>Bidulka P, <b>Fu EL</b>, Leyrat C, Kalogirou F, McAllister KSL, Kingdon EJ, Mansfield KE, Iwagami M, Smeeth L, Clase CM, Bhaskaran K, van Diepen M, Carrero JJ, Nitsch D, Tomlinson LA</td><td>Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care.</td><td><i>BMC Med</i></td><td>2020</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/32723383" target="_blank">32723383</a></td></tr><tr><td>Clase CM, <b>Fu EL</b>, Joseph M, Beale RCL, Dolovich MB, Jardine M, Mann JFE, Pecoits-Filho R, Winkelmayer WC, Carrero JJ</td><td>Cloth Masks May Prevent Transmission of COVID-19: An Evidence-Based, Risk-Based Approach.</td><td><i>Ann Intern Med</i></td><td>2020</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/32441991" target="_blank">32441991</a></td></tr><tr><td>Trevisan M, <b>Fu EL</b>, Szummer K, Norhammar A, Lundman P, Wanner C, Sjölander A, Jernberg T, Carrero JJ</td><td>Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarction.</td><td><i>Eur Heart J Cardiovasc Pharmacother</i></td><td>2021</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/31999317" target="_blank">31999317</a></td></tr><tr><td><b>Fu EL</b>, Trevisan M, Clase CM, Evans M, Lindholm B, Rotmans JI, van Diepen M, Dekker FW, Carrero JJ</td><td>Association of Acute Increases in Plasma Creatinine after Renin-Angiotensin Blockade with Subsequent Outcomes.</td><td><i>Clin J Am Soc Nephrol</i></td><td>2019</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/31395593" target="_blank">31395593</a></td></tr><tr><td><b>Fu EL</b>, Franko MA, Obergfell A, Dekker FW, Gabrielsen A, Jernberg T, Carrero JJ</td><td>High-sensitivity C-reactive protein and the risk of chronic kidney disease progression or acute kidney injury in post-myocardial infarction patients.</td><td><i>Am Heart J</i></td><td>2019</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/31382219" target="_blank">31382219</a></td></tr><tr><td><b>Fu EL</b>, Groenwold RHH, Zoccali C, Jager KJ, van Diepen M, Dekker FW</td><td>Merits and caveats of propensity scores to adjust for confounding.</td><td><i>Nephrol Dial Transplant</i></td><td>2019</td><td><a href="http://www.ncbi.nlm.nih.gov/pubmed/30215791" target="_blank">30215791</a></td></tr>
					</tbody>
				</table>
			</div>
    	</section>

    <!-- Scripts -->
    <script src="../assets/js/navbar.js"></script>
    <script src="../assets/js/jquery.min.js"></script>
    <script src="../assets/js/jquery.scrollex.min.js"></script>
    <script src="../assets/js/jquery.scrolly.min.js"></script>
    <script src="../assets/js/browser.min.js"></script>
    <script src="../assets/js/breakpoints.min.js"></script>
    <script src="../assets/js/util.js"></script>
    <script src="../assets/js/main.js"></script>

  </body>
</html>
